retatrutide ly3437943 clinical trials Incretin triple agonist (LY3437943) alleviates obesity-associated cancer progression Integrated Clinical Trial Services |
Pay in 4 interest-free payments of $5.12 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16























